A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
Public ClinicalTrials.gov record NCT07361497. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ROSETTA Lung-201: A Randomized, Multicenter, Open-label Phase 3 Study of Pumitamig Monotherapy Compared to Durvalumab in Participants With Unresectable Stage III NSCLC Without Progression After Platinum-based Concurrent Chemoradiation Therapy.
Study identification
- NCT ID
- NCT07361497
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 850 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 15, 2026
- Primary completion
- Sep 17, 2030
- Completion
- Dec 30, 2033
- Last update posted
- May 13, 2026
2026 – 2033
United States locations
- U.S. sites
- 38
- U.S. states
- 20
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southern Cancer Center Pc | Daphne | Alabama | 36526 | Recruiting |
| Local Institution - 0780 | Chandler | Arizona | 85224 | Not yet recruiting |
| Local Institution - 0585 | Golden | Colorado | 80401 | Not yet recruiting |
| Medical Oncology Hematology Consultants, PA | Newark | Delaware | 19713 | Recruiting |
| Local Institution - 0711 | Ocala | Florida | 34474 | Not yet recruiting |
| Local Institution - 0756 | Marietta | Georgia | 30060 | Not yet recruiting |
| Local Institution - 0398 | Chicago | Illinois | 60637 | Not yet recruiting |
| Local Institution - 0850 | Evanston | Illinois | 60201 | Not yet recruiting |
| Illinois Cancer Care | Peoria | Illinois | 61615 | Recruiting |
| Fort Wayne Medical Oncology and Hematology | Fort Wayne | Indiana | 46804 | Recruiting |
| Local Institution - 0656 | Lexington | Kentucky | 40536-0284 | Not yet recruiting |
| Local Institution - 0603 | Boston | Massachusetts | 02114-2621 | Not yet recruiting |
| Local Institution - 0419 | Detroit | Michigan | 48201 | Not yet recruiting |
| Minnesota Oncology Hematology | Maple Grove | Minnesota | 55369 | Recruiting |
| Local Institution - 0142 | Saint Paul | Minnesota | 55102 | Not yet recruiting |
| Missouri Cancer Associates | Columbia | Missouri | 65201 | Recruiting |
| Local Institution - 0606 | New York | New York | 10065 | Not yet recruiting |
| Local Institution - 0339 | Westbury | New York | 11590 | Withdrawn |
| Local Institution - 0909 | Westbury | New York | 11590 | Not yet recruiting |
| Local Institution - 0493 | Winston-Salem | North Carolina | 27103 | Not yet recruiting |
| Local Institution - 0923 | Akron | Ohio | 44302 | Not yet recruiting |
| Local Institution - 0412 | Cincinnati | Ohio | 45219 | Not yet recruiting |
| Local Institution - 0359 | Cleveland | Ohio | 44106-5066 | Not yet recruiting |
| Local Institution - 0597 | Cleveland | Ohio | 44195 | Not yet recruiting |
| Local Institution - 0924 | Mayfield Heights | Ohio | 44124 | Not yet recruiting |
| Oncology Associates Of Oregon, Pc | Eugene | Oregon | 97401 | Recruiting |
| Northwest Cancer Specialists, P.C. | Happy Valley | Oregon | 97015 | Recruiting |
| Local Institution - 0480 | Nashville | Tennessee | 37203 | Not yet recruiting |
| SCRI Oncology Partners | Nashville | Tennessee | 37203 | Recruiting |
| Texas Oncology - Amarillo Cancer Center | Amarillo | Texas | 79124 | Recruiting |
| Texas Oncology-Austin Central | Austin | Texas | 78731 | Recruiting |
| Texas Oncology | Denton | Texas | 76210 | Recruiting |
| Local Institution - 0811 | Fort Worth | Texas | 76104 | Not yet recruiting |
| Local Institution - 0596 | Houston | Texas | 77030 | Not yet recruiting |
| Texas Oncology - San Antonio Medical Center | San Antonio | Texas | 78229 | Recruiting |
| Texas Oncology - Northeast Texas | Tyler | Texas | 75702 | Recruiting |
| Blue Ridge Cancer Care | Christiansburg | Virginia | 24073 | Recruiting |
| Virginia Oncology Associates | Norfolk | Virginia | 23502 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 216 non-U.S. sites.
Recently updated Non-small Cell Lung Cancer (NSCLC) trials
Other public records listing Non-small Cell Lung Cancer (NSCLC). Sorted by last update posted; newest first. Not a recommendation.
- NCT07777822: Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC Recruiting
- NCT07660055: Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors Recruiting
- NCT06476808: A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. Recruiting
- NCT07566052: A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation Recruiting
- NCT05589818: Pembrolizumab for Advanced NSCLC and PS 2-3 Recruiting
- NCT07540572: A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07361497, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07361497 live on ClinicalTrials.gov.